Literature DB >> 14514579

Prediction of coronary heart disease in middle-aged adults with diabetes.

Aaron R Folsom1, Lloyd E Chambless, Bruce B Duncan, Adam C Gilbert, James S Pankow.   

Abstract

OBJECTIVE: To determine the 10-year probability of coronary heart disease (CHD) in diabetic adults and how well basic and novel risk factors predict CHD risk. RESEARCH DESIGN AND METHODS: We measured risk factors in 14054 participants (1500 with diabetes) initially free of CHD in the Atherosclerosis Risk in Communities study from 1987 to 1989 and followed them prospectively for CHD incidence through 1998. We used proportional hazards regression models and receiver operating characteristic (ROC) curves for CHD risk prediction.
RESULTS: Based on our model using basic risk factors (age, race, total and HDL cholesterol, systolic blood pressure, antihypertensives, and smoking status), approximately 61% of diabetic women and 86% of diabetic men had a predicted 10-year CHD probability >or=10%. This CHD risk-prediction model had an area under the ROC curve of 0.72 in diabetic women and 0.67 in diabetic men. Novel risk factors or subclinical disease markers individually added only modest predictivity, but the addition of multiple markers (BMI, waist-to-hip ratio, Keys dietary score, serum albumin and creatinine, factor VIII, white blood cell count, left ventricular hypertrophy determined by electrocardiogram, and carotid intima-media thickness) increased the area under the curve by approximately 10%.
CONCLUSIONS: Although all diabetic adults are at high risk for CHD, their variation in CHD risk can be predicted moderately well by basic risk factors. No single novel risk marker greatly enhanced absolute CHD risk assessment, but a battery of novel markers did. Our model can provide estimates of CHD risk for the primary prevention of this disease in people with type 2 diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 14514579     DOI: 10.2337/diacare.26.10.2777

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  42 in total

1.  Assessment of atrial conduction time by tissue Doppler echocardiography and P-wave dispersion in smokers.

Authors:  Erdal Akturk; Jülide Yağmur; Nusret Açıkgöz; Necip Ermiş; Mehmet Cansel; Yasin Karakuş; Hakan Taşolar; Ferhat Eyupkoca; Hasan Pekdemir
Journal:  J Interv Card Electrophysiol       Date:  2012-03-06       Impact factor: 1.900

2.  Cardiac risk factors in patients with diabetes mellitus and major depression.

Authors:  Wayne J Katon; Elizabeth H B Lin; Joan Russo; Michael Von Korff; Paul Ciechanowski; Greg Simon; Evette Ludman; Terry Bush; Bessie Young
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

3.  Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.

Authors:  C M Parrinello; K Matsushita; M Woodward; L E Wagenknecht; J Coresh; E Selvin
Journal:  Diabetes Obes Metab       Date:  2016-06-14       Impact factor: 6.577

Review 4.  Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Authors:  Yukako Tatsumi; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

5.  Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Authors:  Anandita Agarwala; Salim Virani; David Couper; Lloyd Chambless; Eric Boerwinkle; Brad C Astor; Ron C Hoogeveen; Joe Coresh; A Richey Sharrett; Aaron R Folsom; Tom Mosley; Christie M Ballantyne; Vijay Nambi
Journal:  Atherosclerosis       Date:  2016-08-25       Impact factor: 5.162

6.  Cardiovascular Disease Incidence and Risk Factor Patterns among Omanis with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Abdul Hakeem Al Rawahi; Patricia Lee; Zaher A M Al Anqoudi; Ahmed Al Busaidi; Muna Al Rabaani; Faisal Al Mahrouqi; Ahmed M Al Busaidi
Journal:  Oman Med J       Date:  2017-03

7.  Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.

Authors:  Eric Y Yang; Vijay Nambi; Zhengzheng Tang; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Brad C Astor; Thomas H Mosley; Josef Coresh; Lloyd Chambless; Christie M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

8.  Letter: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100).

Authors:  Kyu-Chang Won
Journal:  Korean Diabetes J       Date:  2010-06-30

9.  Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

Authors:  Maximilian von Eynatten; Dan Liu; Cornelia Hock; Dimitrios Oikonomou; Marcus Baumann; Bruno Allolio; Grigorios Korosoglou; Michael Morcos; Valentina Campean; Kerstin Amann; Jens Lutz; Uwe Heemann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.